$Applied DNA Sciences (APDN.US)$ To grant the board of directors of the Company (the “Board”) discretionary authority for 12 months to amend the Company’s certificate of incorporation, as amended, to authorize a reverse stock split of common stock, at a ratio in the range from one-for-five to one-for-fifty, with such specific ratio to be determined by the Company’s Board following the Annual Meeting.
2
104294070
commented on
$Applied DNA Sciences (APDN.US)$ anyone know what’s wrong?
2
104294070
commented on
$Applied DNA Sciences (APDN.US)$ H.C. Wainwright has lowered their price target for Applied DNA Sciences shares, while maintaining a Buy rating.
A public offering is expected to generate approximately $12 million in gross proceeds. Lastly, the company received approval from the New York State Department of Health for its pharmacogenomic testing service, TR8, and plans to implement a reverse stock split to comply with Nasdaq's listing rules.
A public offering is expected to generate approximately $12 million in gross proceeds. Lastly, the company received approval from the New York State Department of Health for its pharmacogenomic testing service, TR8, and plans to implement a reverse stock split to comply with Nasdaq's listing rules.
1
1
104294070
commented on
$Tonix Pharmaceuticals (TNXP.US)$ Tonix Pharmaceuticals Holding Corp. has announced a Special Meeting of shareholders to be held virtually on October 30, 2024. The meeting will address two key proposals: a reverse stock split of the company's common stock and an amendment to increase the authorized shares of common stock to 1 billion if a reverse stock split is effectuated prior to the approval of the Reverse Stock Split Proposal. Shareholders of record as of September 12, 2024, are entitled to v...
1
4
104294070
commented on
$LogicMark (LGMK.US)$ what's happening to this stock, more ppl r coming in but the price is falling... smh
3
2
$FSD Pharma (HUGE.US)$ Many big investor already sold it,reverse stock split cause dillution. If this stock is value,just buy it after reverse stock split.
5
3
$LogicMark (LGMK.US)$ Be careful for the reverse stock split❗❗❗Don't Hold
To authorize the Board, for purposes of maintaining compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth under Nasdaq Rule 5550(a)(2), to amend the Company’s articles of incorporation, as amended, as then in effect (the “Charter”), to effect a reverse stock split of all of the Company’s outstanding shares of common stock, par value $0.0001 per share (the “Common...
To authorize the Board, for purposes of maintaining compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth under Nasdaq Rule 5550(a)(2), to amend the Company’s articles of incorporation, as amended, as then in effect (the “Charter”), to effect a reverse stock split of all of the Company’s outstanding shares of common stock, par value $0.0001 per share (the “Common...
$FSD Pharma (HUGE.US)$ Dont hold,it will have reverse stock split on 15 August.
FSD Pharma Inc., a biopharmaceutical company, has announced a major stock consolidation and a rebranding as Quantum BioPharma Ltd. The consolidation will see shares reduced on a 65-to-1 basis, aiming to comply with Nasdaq’s minimum bid price requirement. Commencing on August 15, 2024, the new QNTM shares will trade on both the CSE and Nasdaq.
FSD Pharma Inc., a biopharmaceutical company, has announced a major stock consolidation and a rebranding as Quantum BioPharma Ltd. The consolidation will see shares reduced on a 65-to-1 basis, aiming to comply with Nasdaq’s minimum bid price requirement. Commencing on August 15, 2024, the new QNTM shares will trade on both the CSE and Nasdaq.
3
2
104294070
commented on
$Presto Automation (PRST.US)$ OTC stock❗❗❗
The Company expects that the trading of its common stock will transition to the OTC Bulletin Board or “pink sheets” market shortly. The transition to over-the-counter markets is not expected to affect the Company’s operations or business and does not change its reporting requirements under SEC rules. The Company cannot predict what the impact of the transition will be on the liquidity in its Common Stock.
The Company expects that the trading of its common stock will transition to the OTC Bulletin Board or “pink sheets” market shortly. The transition to over-the-counter markets is not expected to affect the Company’s operations or business and does not change its reporting requirements under SEC rules. The Company cannot predict what the impact of the transition will be on the liquidity in its Common Stock.
1
4